Bantie L, Tadesse S, Likisa J, Yu M, et al. Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838]. Gynecol Oncol 2021 Jul 30. pii: S0090-8258(21)00580.
PMID: 34340816